Accelerating Precision Drug Development and Drug Repurposing by Leveraging Human Genetics.

Saved in:
Bibliographic Details
Title: Accelerating Precision Drug Development and Drug Repurposing by Leveraging Human Genetics.
Authors: Pulley JM; 1 Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center , Nashville, Tennessee., Shirey-Rice JK; 1 Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center , Nashville, Tennessee., Lavieri RR; 1 Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center , Nashville, Tennessee., Jerome RN; 1 Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center , Nashville, Tennessee., Zaleski NM; 1 Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center , Nashville, Tennessee., Aronoff DM; 2 Department of Medicine, Division of Infectious Diseases, Vanderbilt University School of Medicine , Nashville, Tennessee.; 3 Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center , Nashville, Tennessee., Bastarache L; 4 Department of Biomedical Informatics, Vanderbilt University School of Medicine , Nashville, Tennessee., Niu X; 4 Department of Biomedical Informatics, Vanderbilt University School of Medicine , Nashville, Tennessee., Holroyd KJ; 1 Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center , Nashville, Tennessee.; 5 Center for Technology Transfer and Commercialization, Vanderbilt University , Nashville, Tennessee., Roden DM; 6 Office of Research, Vanderbilt University Medical Center , Nashville, Tennessee., Skaar EP; 7 Department of Pathology, Microbiology, and Immunology, Division of Molecular Pathogenesis, Vanderbilt University School of Medicine , Nashville, Tennessee., Niswender CM; 8 Department of Pharmacology, Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University Medical Center , Nashville, Tennessee.; 9 Vanderbilt Kennedy University Center for Excellence in Development Disabilities, Nashville, Tennessee., Marnett LJ; 10 Department of Chemistry, Vanderbilt University , Nashville, Tennessee.; 11 Department of Biochemistry, Vanderbilt University Medical School , Nashville Tennessee., Lindsley CW; 10 Department of Chemistry, Vanderbilt University , Nashville, Tennessee.; 12 Department of Medicinal Chemistry, Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University Medical Center , Nashville, Tennessee., Ekstrom LB; 1 Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center , Nashville, Tennessee.; 13 Nashville Biosciences, Nashville, Tennessee., Bentley AR; 5 Center for Technology Transfer and Commercialization, Vanderbilt University , Nashville, Tennessee., Bernard GR; 1 Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center , Nashville, Tennessee.; 6 Office of Research, Vanderbilt University Medical Center , Nashville, Tennessee., Hong CC; 14 Department of Medicine, Division of Cardiovascular Medicine, Vanderbilt University School of Medicine , Nashville, Tennessee.; 15 Department of Cell and Developmental Biology, Vanderbilt University School of Medicine , Nashville, Tennessee., Denny JC; 4 Department of Biomedical Informatics, Vanderbilt University School of Medicine , Nashville, Tennessee.
Source: Assay and drug development technologies [Assay Drug Dev Technol] 2017 Apr; Vol. 15 (3), pp. 113-119. Date of Electronic Publication: 2017 Apr 05.
Publication Type: Journal Article; Technical Report
Journal Info: Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101151468 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-8127 (Electronic) Linking ISSN: 1540658X NLM ISO Abbreviation: Assay Drug Dev Technol Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first